ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
94 263,77
-3,02%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Kezar Life Sciences Inc (KZR) Cours

Kezar Life Sciences Inc

Kezar Life Sciences Inc (KZR)

Kalamazoo Resources Limited
6,38
-0,14
(-2,15%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes
6,36
-0,02
(-0,31%)
Après les heures de négociation: 11:20PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
6,36
Prix Achat
6,30
Prix Vente
6,72
Volume échangé
75 106
6,35 Fourchette du Jour 6,75
5,016 Plage de 52 semaines 11,35
Cap du marché
46,404M
Clôture Veille
6,52
Ouverture
6,49
Dernière Transaction
70
@
6.36
Dernière heure de transaction
Volume financier
US$ 493 359
VWAP
6,5688
Volume moyen (3 m)
734 132
Actions en circulation
7 296 222
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,46
Bénéfice par action (BPA)
-13,96
Chiffre d'affairess
7M
Bénéfice net
-101,87M

À propos de Kezar Life Sciences Inc

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
kezarlifesciences.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Kezar Life Sciences Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker KZR. Le dernier cours de clôture d'Kezar Life Sciences était de US$6,52. Au cours de la dernière année, les actions de Kezar Life Sciences ont été négociées dans une fourchette de prix de US$ 5,016 à US$ 11,35.

Kezar Life Sciences compte actuellement 7 296 222 actions en circulation. La capitalisation boursière d'Kezar Life Sciences est de US$47,57 million. Kezar Life Sciences a un ratio cours/bénéfice (ratio PE) de -0.46.

KZR Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

03 Décembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update

Topline data from PORTOLA Phase 2a clinical trial evaluating zetomipzomib in patients with autoimmune hepatitis (AIH) expected in first half 2025 Cash, cash equivalents and marketable securities...

12 Novembre 2024
Business Wire

Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]

29 Octobre 2024
Edgar (US Regulatory)

Form 8-K - Current report

28 Octobre 2024
Edgar (US Regulatory)

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...

28 Octobre 2024
Business Wire

Form 8-A12B - Registration of securities [Section 12(b)]

17 Octobre 2024
Edgar (US Regulatory)

Form 8-K - Current report

17 Octobre 2024
Edgar (US Regulatory)

Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...

17 Octobre 2024
Business Wire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.43-6.332842415326.796.966.16480436.49297105CS
4-1.045-14.11208642817.4057.616.16579356.94969556CS
121.03319.39177773615.3279.185.0167341327.85540405CS
26-0.28-4.216867469886.649.185.0166179787.05078237CS
52-2.18-25.52693208438.5411.355.0166291547.85528414CS
156-137.24-95.5710306407143.6185.55.01684213753.11462295CS
260-26.64-80.727272727333185.55.01668809160.7375442CS

KZR - Frequently Asked Questions (FAQ)

What is the current Kezar Life Sciences share price?
The current share price of Kezar Life Sciences is US$ 6,36
How many Kezar Life Sciences shares are in issue?
Kezar Life Sciences has 7 296 222 shares in issue
What is the market cap of Kezar Life Sciences?
The market capitalisation of Kezar Life Sciences is USD 47,57M
What is the 1 year trading range for Kezar Life Sciences share price?
Kezar Life Sciences has traded in the range of US$ 5,016 to US$ 11,35 during the past year
What is the PE ratio of Kezar Life Sciences?
The price to earnings ratio of Kezar Life Sciences is -0,46
What is the cash to sales ratio of Kezar Life Sciences?
The cash to sales ratio of Kezar Life Sciences is 6,65
What is the reporting currency for Kezar Life Sciences?
Kezar Life Sciences reports financial results in USD
What is the latest annual turnover for Kezar Life Sciences?
The latest annual turnover of Kezar Life Sciences is USD 7M
What is the latest annual profit for Kezar Life Sciences?
The latest annual profit of Kezar Life Sciences is USD -101,87M
What is the registered address of Kezar Life Sciences?
The registered address for Kezar Life Sciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Kezar Life Sciences website address?
The website address for Kezar Life Sciences is kezarlifesciences.com
Which industry sector does Kezar Life Sciences operate in?
Kezar Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
KZR
Kezar Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés